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ABSTRACT  
Objective: Synthesis of silver nanoparticles using Streptomyces sp. PG12 and their characterization, antimicrobial activity and cytotoxicity against 
A549 and MCF-7 cancer cell lines. 
Methods: The silver nanoparticles were subjected to UV-Vis. spectroscopy, Fourier transform infrared spectroscopy (FTIR), scanning electron 
microscopy with energy-dispersive X-ray spectroscopy (SEM/EDS), high-resolution transmission electron microscopy (HR-TEM), zeta potential, 
and X-ray diffractometry (XRD) analyses. Further, the antimicrobial potential was determined by using the agar well diffusion method and 
cytotoxicity was determined with the help of cell viability (MTT) assay and reactive oxygen species (ROS) assay.  
Results: The initial indication of silver nanoparticles synthesis was noticed by the colour change in the reaction mixture and the absorption 
maximum at 421 nm in UV-Vis. analysis; whereas, the FTIR analysis displayed the biological functional groups responsible for the capping and 
stabilization of silver nanoparticles. SEM and TEM micrographs revealed the surface morphology, spherical shape, and smallest particle size as 
18.91 nm. The EDS and XRD patterns confirmed the involvement of various elements during the synthesis of silver nanoparticles and the crystalline, 
face-centered cubic nature, respectively. The silver nanoparticles displayed considerable antimicrobial activity against human pathogens even at 
low MIC and MBC concentrations and exhibited increased anticancer activity against A549 and MCF-7 cell lines, where the ability of silver 
nanoparticles to significantly restrict the growth of tumour cells was observed at IC50 values of 69.04µg/ml and 138.30µg/ml, respectively. 
Conclusion: Streptomyces sp. PG12 synthesized silver nanoparticles show significant anticancer activity against A549 and MCF-7 cell lines.  
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INTRODUCTION 
Nanotechnology is the concept that deals with the production, 
manipulation, characterization, and applications of nano-scale 
materials whose size usually ranges between 1 to 100 nm. Nano-
materials prepared from metals offer unique properties of size, 
shape, and larger surface area to volume ratio [1]. In the recent 
decade, these metal nanoparticles prepared using gold, silver, 
platinum, copper, zinc, lead, iron, and many more are extensively 
used for various applications in divergent fields such as nano-
medicine, electrical, agriculture, pharmaceuticals, cosmetics, food 
industry, textiles, and data storage [2, 3].  
Silver is more often considered for synthesizing nanoparticles due to 
potential antimicrobial, antioxidant, anti-inflammatory, and anticancer 
activities. The recent advancements in nano-science have pointed out 
the significance of silver nanoparticles (AgNPs) in the areas of 
biomedical, DNA sequencing, biological sensors, plasmonics, catalysis, 
energy generation, and clean water technology [4, 5]. Generally, AgNPs 
are produced by one of two paths, i.e., ‘top-down’ or ‘bottom-up’ 
strategies via physical or chemical or biological synthesis routes. The 
physical and chemical techniques require more energy, thermal 
ablation, and hazardous chemicals that are carcinogenic and induce 
genotoxicity. Hence, due to its low cost, non-toxicity, and eco-friendly 
nature, the biological synthesis method is essential [6, 7]. 
The greener approach of AgNPs synthesis is carried out by 
employing biological resources like algae, lichens, bacteria, yeast, 
fungi, actinobacteria, and plant extracts. Among the microorganisms, 
bacteria are considered the ideal source for metal nanoparticles 
synthesis, owing to their metal resistance mechanism, which helps 
them reduce ionic silver (Ag+) into elemental (Ag°) NPs [8, 9]. The 
microbial synthesis method of AgNPs allows for safer, cheaper, and 
more stable metallic AgNPs as the microbes produce various 
secondary metabolites, which actively participate in the reduction, 
capping, and stabilization [10]. 
The increasing multi-drug resistance in human pathogenic 
microorganisms is of great concern, and there is an urgent need for 
the development of broad-spectrum antimicrobials to treat severe 
infections. The AgNPs have gained importance as the alternative for 
antibacterial and antifungal agents and help reduce toxicity, avoid 
the side effects in patients, and prevent pathogens [11, 12]. Cancer is 
ranked top on the list of deadly diseases as the second leading cause 
for the most deaths across the globe, and the numbers are expected 
to increase further [13]. From the past few decades, AgNPs are 
extensively used as cytotoxic agents against various human cancers. 
The microbial AgNPs synthesized using species of Pseudomonas [14], 
Enterococcus [15], and Streptomyces [16, 17] have successfully 
prevented the growth of tumour cells.  
Actinomycetes belong to Gram-positive, aerobic and filamentous 
bacteria with high G+C content. Many of the Actinomycetales 
members are known for their peculiar capacity to produce bioactive 
secondary metabolites having properties from antimicrobial to 
anticancer and many more [18-20]. Because of these essential 
biological properties of actinobacterial secondary metabolites, the 
culture filtrate of Streptomyces sp. PG12 was to investigate for the 
extracellular synthesis of AgNPs and their evaluation for 
antimicrobial and anticancer potential. 
MATERIALS AND METHODS 
Collection of pathogens  
The pathogenic microorganisms such as Staphylococcus aureus 
(MTCC6908), Pseudomonas aeruginosa (MTCC424), Enterococcus 
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faecalis (MTCC6845), Escherichia coli (MTCC40), Alternaria alternata 
(MTCC2060), Fusarium oxysporum (MTCC2087), Candida albicans 
(MTCC227), and Candida glabrata (MTCC3814) were procured from 
Institute of Microbial Technology, Chandigarh, India. 
Isolation of actinobacterial strains 
During the present study, the marine samples were collected from 
Maravanthe beach, Kundapura, Karnataka, India. The serially diluted 
samples were inoculated onto starch casein agar (SCA) media plates. 
The plates were subjected to incubation at 30 °C for 5 d, and 45 
Actinomycete strains were isolated. From these 45 isolates, a single 
Actinomycete was selected for the green AgNPs synthesis and 
designated as strain PG12. 
Genotypic characterization of the isolate 
The fresh culture of strain PG12 was employed to extract genomic 
DNA using the instructions of Hi-PurA DNA purification kit 
manufacturers. The 16S rRNA gene was sequenced (Sanger 
Sequencing 3500 Series, Genetic Analyzer) and deposited to the NCBI 
database via nucleotide BLAST web portal. Similar DNA sequences 
were selected to construct a phylogenetic tree using MegAlign Pro 17 
(DNASTAR Lasergene) software as per the standard procedures [21]. 
Preparation of cell-free extract 
The strain PG12 was inoculated into a 250 ml Erlenmeyer flask with 
sterile starch casein broth. A rotary shaker at a speed of 200 rpm was 
used to incubate the culture flasks for 5 d at room temperature. After 
incubation, the centrifugation at 10000 rpm (REMI R-24) for 15 min 
was done to obtain the cell-free extract for AgNPs synthesis [21]. 
Biosynthesis of AgNPs 
For the AgNPs synthesis, about 100 ml aqueous solution of 0.1 mmol 
AgNO3 was mixed with 100 ml cell-free supernatant of PG12 strain. 
After adjusting the pH at 8.0, incubation for 5 d under dark conditions 
was followed, and the reduction of silver ions (Ag+) was examined by 
observing the change in colour of the reaction mixture [21]. 
Characterizations of AgNPs 
The reduction of Ag+ into Ag° was recorded using a double beam UV-
Visible spectrophotometer (UV-9600A, METASH Instruments, 
Shanghai, China). The probable biochemical functional groups 
responsible for stabilizing and capping AgNPs were determined by 
FTIR spectrophotometer (Nicolet 6700, Thermo Fisher Scientific, 
Waltham, Massachusetts, USA) scanning from 4000 to 400 cm-1 in 
transmittance mode. The morphology, shape, size, and elemental 
composition of AgNPs were analyzed with SEM/EDS (Jeol, JSM-
IT500 LA, Japan) and HR-TEM (FEI, TECNAI G2, F30) instruments. 
Further, the electrostatic stability and zeta potential was calculated 
(HORIBA nanoparticle analyzer SZ-100, Kyoto, Japan) along with the 
crystalline nature of synthesized AgNPs by X-ray diffractometer 
(Rigaku SmartLab SE, Austin, Texas, US). 
Antimicrobial activity of AgNPs 
The antagonistic activity of Streptomyces sp. PG12 cell-free extract 
mediated AgNPs were determined against pathogenic fungi and 
bacteria using the agar well diffusion method on potato dextrose 
agar and nutrient agar, respectively. The different volumes of AgNPs 
(25, 50, 75, and 100 µl) from the stock suspension of 50 µg/ml 
concentrations were poured in appropriate wells (6 mm) along with 
positive (streptomycin and fluconazole) and negative (distilled 
water) controls. The plates were incubated at 35 °C for 24 h for 
bacterial pathogens and at 35 °C for 72 h for fungal pathogens. The 
formation of inhibition zones were measured as diameter in mm 
with the help of the Hi-antibiotic zone scale-C [22]. 
Evaluation of minimum inhibitory concentration (MIC) and 
minimum bactericidal concentration (MBC) of AgNPs 
The MIC of the synthesized AgNPs on bacterial pathogens was 
determined with broth dilution assay in a 96-well microtitre plate 
with resazurin as standard, whereas; the MBC test was carried out 
on Mueller-Hinton agar plates. About 24 h incubation at 37 °C was 
used for the test plates, and the concentration where no growth of 
bacteria was observed on plates was recorded as the MIC and MBC 
values [22]. 
Anticancer activity assessment of AgNPs 
The cytotoxic activity of strain PG12 mediated AgNPs was 
investigated by employing the 96-well plate MTT cell proliferation 
assay. The cancer cells viz. A549 and MCF-7 cell lines were procured 
from NCCS, Pune, India, and sub-cultured and maintained on 
Dulbecco modified eagle medium (D-MEM) before incubation in a 
5% CO2 incubator at 37 °C. The cancer cells were plated in a 96-well 
plate (Nunc, Thermo Scientific, Cat. No. 265300) at a cell density of 
20,000 cells/well for MTT assay, and ROS assay 10,000 cells/200 µl 
was used. For MTT assay, 3.48 µg/ml camptothecin (MCF-7), 2.58 
µg/ml cisplatin (A549) were taken as standard, and only media with 
cells were taken as control; whereas, appropriate concentrations of 
AgNPs suspensions in dimethyl sulfoxide (DMSO) (12.5, 25, 50, 100 
and 200 µg/ml) were added into respective wells. Finally, tumour 
cell viability was examined recording the absorbance at 570 nm on 
ELISA reader by keeping 630 nm as reference wavelength [23]. 
The ROS assay was conducted by treating the cells with test compounds 
with IC50 concentrations except for cell control in 200 µl of culture 
medium and incubated the cells for 24 h. During ROS expression study, 
2', 7'-dichlorodihydrofluorescein diacetate (H2DCFDA) was used for 
staining the cells, which oxidizes and converts into fluorescent 2', 7'-
dichlorofluorescein (DCF) by the generation of intracellular ROS. The 
cells were observed under a confocal microscope with 488 and 535 nm 
excitation and emission wavelengths for ROS study. All the images were 
recorded at a different time of intervals using an inverted phase-contrast 
microscope (Biolink) [23]. 
Statistical analysis 
All the analysis performed was in triplicate and the data represented 
as mean ± standard deviation. The statistical analysis was performed 
by using GraphPad Prism 4.0 software (San Diego, California, USA).  
RESULTS AND DISCUSSION 
Genotypic characterization of the isolate 
The 16S rRNA gene sequence of 1011 base pairs obtained from the 
strain PG12 was submitted to the NCBI database (Accession No. 
MN235876) and initially characterized by nucleotide BLAST to get 
homologous sequences. A neighbor-joining phylogenetic tree was 
constructed using the homologous sequences of various other 
species in which the strain PG12 showed the highest similarity 
with Streptomyces sp. strain Al-Dhabi-87 (fig. 1). Similarly, a strain 
CGG11n of actinobacteria identified based on 16S rRNA gene 
sequencing and phylogenetic tree analysis was reported [24]. 
Visual and UV-Vis analysis 
The initial indication of AgNPs synthesis was noticed by the change 
in colour of the reaction mixture; the supernatant was orange-brown 
before adding 1 mmol AgNO3 solution, the colour turned dark brown 
after adding AgNO3 and incubation in the dark (fig. 2A). The further 
confirmation on the synthesis of AgNPs was determined by sharp 
absorption maximum at 421 nm in UV-Vis. spectrophotometer (fig. 
2B). Similar observations about the colour change in the reaction 
mixture after mixing with AgNO3 were reported and mentioned that 
the colour change is due to reducing silver ions in the AgNO3 
solution. Due to surface plasmon resonance (SPR) excitation, a sharp 
peak was obtained, confirming the AgNPs formation from the 
supernatant of strain PG12 [25, 26]. 
FTIR analysis 
The FTIR analysis was carried out in transmittance mode from 4000 to 
400 cm-1 to recognize possible biochemical functional groups 
responsible for the AgNPs capping and stabilization. The FTIR 
spectrum of strain PG12 mediated AgNPs shown various characteristic 
peaks, which could be related to specific functional groups (fig. 3). The 
broad intensity peak at 3270 cm-1 corresponds to H-bonded free 
alcohols/phenols, whereas the small intensity peak at 2925 cm-1 is 
attributed to C-H stretching alkanes. The sharp, medium intensity 
peaks at 1725 and 1634 cm-1 were correlated to C=O bonded 
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aldehydes and amides, respectively. The small intensity peaks at 1377 
and 1229 cm-1 corresponded to N=O bonded nitro compound (R-NO2) 
and S=O bonded sulfates and sulfonamides. The strong intensity peak 
at 1026 cm-1 relates to C-N bonded amines, and the weak peak at 446 
cm-1 is attributed to C-X bonded halides. The functional groups that 
helped in the synthesis of AgNPs were identified by observing a shift in 
absorption spectra. These results suggest the critical role of biological 
molecules in the AgNPs synthesis along with stabilization by having 
the ability to link to metal. The presence of active functional groups 
indicates effective reduction and capping of AgNPs [27, 28]. 
 
 
Fig. 1: Phylogenetic tree of the isolate Streptomyces sp. PG12 
 
 
Fig. 2: Visual and UV-Vis. analysis of Streptomyces sp. PG12 AgNPs; A) colour change in the reaction mixture before and after adding 
AgNO3, B) A sharp peak obtained in UV-Vis. absorption spectrum 
 
 
Fig. 3: FTIR spectrum of Streptomyces sp. PG12 AgNPs 
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SEM with EDS analysis 
The morphological details of synthesized AgNPs were ascertained by 
SEM imaging, where the shape and distribution of AgNPs were found 
to be spherical and polydispersed, respectively. The EDS analysis 
revealed Ag at 3 keV and various elements such as C, O, Na, Cl, K, and 
Ca, which involved the capping of synthesized AgNPs (fig. 4A and 
4B). The previous SEM analysis results of green AgNPs suggested the 
spherical shape, poly-dispersed AgNPs from the microbial origin, 
and most of the particles had a smooth surface with a compact 
arrangement. Similarly, the strong signal peak at 3 keV in the EDS 
spectrum was due to the SPR of metallic silver. The analysis 
confirmed AgNPs synthesis with suggesting silver as the significant 
ingredient element [29, 30]. 
 
 
Fig. 4: SEM with EDS analysis of Streptomyces sp. PG12 AgNPs, A) SEM image showing morphology and distribution of AgNPs, B) EDS 
spectrum showing peaks for various elements 
 
HR-TEM analysis 
TEM analysis was performed to understand the morphological details 
of synthesized AgNPs, and the images confirmed the spherical shape of 
synthesized AgNPs (fig. 5A). The TEM data depicted the poly-dispersed 
nature of AgNPs with few agglomerates, and the AgNPs ranged from 
20 to 32 nm in size with the smallest particle size of 18.91 nm (fig. 5B). 
These findings agreed with the previous studies on TEM analysis of 
AgNPs, where the biogenic AgNPs were spherical, poly-dispersed, and 
ranged from 20 to 50 nm in size. The TEM micrograph also revealed 
the uneven distribution of AgNPs with a negligible amount of 
agglomeration; the small sizes of particles have a crucial role in the 
penetration process inside microbial cells to induce a cascade of 
events that lead to cell death [31, 32]. 
  
 
Fig. 5: HR-TEM analysis of Streptomyces sp. PG12 AgNPs, A) TEM micrograph showing surface morphology and distribution of AgNPs, B) 
Image showing average size of AgNPs 
 
 
Fig. 6: Graph showing zeta potential of Streptomyces sp. PG12 AgNPs 
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Zeta potential analysis 
The stability of synthesized AgNPs was determined with zeta 
potential studies and the potential value of Streptomyces sp. PG12 
AgNPs were determined to be -43.2 mV (fig. 6). Along with the 
stability, zeta analysis indicated the high dispersivity and well-
defined colloidal nature of the AgNPs. This result was well 
supported by the previous studies on zeta potentials of AgNPs, 
hinting that the higher negative value attributes to the higher 
stability of AgNPs [33, 34]. 
XRD analysis 
The XRD pattern obtained from PG12 AgNPs indicated four firm 
Bragg’s peaks in the 2θ range of 30⁰ to 80⁰, confirming the synthesis 
of AgNPs. The four Bragg’s peaks were obtained at (111), (200), 
(220), and (311) for 2θ angles of 38.13⁰, 46.21⁰, 64.48⁰, and 77.42⁰ 
determined the face-centered cubic nature of the synthesized AgNPs 
(fig. 7). Similar XRD patterns were observed in previous studies on 
AgNPs from Streptomyces albogriseolus [35] and Streptomyces sp. 
AS3 [36], suggesting the large crystalline domain sizes 
corresponding to pure silver metal. According to the previous 
reports, the extra peaks were due to the bio-organic phase present 
on the surface of AgNPs, and the more width of the peaks relates to 
the smaller particle size. The obtained results of characteristic peaks 
were verified with the JCPDS database. 
Antimicrobial activity of AgNPs 
The dried AgNPs powder was washed and re-suspended in distilled 
water before testing antimicrobial activity on pathogenic 
microorganisms. Among the selected bacterial pathogens, E. faecalis 
was the most sensitive with inhibition zones of 19, 21, 21, and 23 mm 
for 25, 50, 75, and 100 µl of AgNPs suspensions, respectively. For 
fungal pathogens, AgNPs showed the highest activity against A. 
alternata with 18, 19, 20, and 21 mm inhibition zones for 25, 50, 75, 
and 100 µl, respectively; whereas S. aureus, P. aeruginosa, and F. 
oxysporum were found to be less sensitive for AgNPs (fig. 8). The 
previous antimicrobial activity results suggested that Streptomyces 
olivaceus (MSU3) mediated AgNPs effectively suppressed the growth 
of S. pneumoniae, S. mutant, K. pneumoniae, and E. coli at 30 µl [37]. 
Similarly, Streptomyces parvus (Al-Dhabi-91) showed increased 
antimicrobial activity even at low concentrations against pathogenic 
bacteria. Also, they suggested that the AgNPs may interact with 
microbial cell walls and lipopolysaccharides and disrupt them. Finally, 
the AgNPs leads to cell death when entering into the bacterial cell and 
binds to enzymes, proteins, and DNA by disrupting the cellular 
biochemical reactions and DNA replication mechanism [38]. 
 
 
Fig. 7: XRD pattern of Streptomyces sp. PG12 AgNPs 
 
 
Fig. 8: Antimicrobial activity of Streptomyces sp. PG12 AgNPs against microbial pathogens, *values are the mean of three replicates±SD 
 
Evaluation of MIC and MBC 
The MIC can be defined as the minimum concentration of an 
antibiotic substance required to prevent bacterial growth, and the 
minimum concentration necessary to kill the pathogen is referred to 
as the MBC value. The biosynthesized AgNPs showed considerable 
MIC and MBC values against the test pathogens (table 1) and 
successfully inhibited the pathogens even at very low 
concentrations. Similar results were obtained in previous 
investigations, where the biological AgNPs at low concentrations 
showed high inhibitory activity against pathogens like E. coli, E. 
faecalis, S. aureus, and S. pneumoniae. They concluded that the AgNPs 
with smaller sizes provide a larger surface area for interaction with 
the microbial cell membrane, adding to the alterations in some 
primary functions of bacteria, such as permeability and cell 
respiration [39]. 
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Table 1: MIC and MBC values of Streptomyces sp. PG12 AgNPs against pathogenic bacteria, *values are in mean three replicates±SD 
S. No. Name of the pathogen MIC (µg/ml) MBC (µg/ml) 
1. S. aureus 128 128 
2. E. faecalis 32 32 
3. S. pneumoniae 32 64 
4. E. coli 64 64 
 
Anticancer activity of AgNPs 
The cytotoxicity of AgNPs was evaluated on A549 and MCF-7 cell lines 
by employing both MTT assay and ROS expression study with 6.25 to 
100 µg/ml AgNPs concentrations and IC50 concentration at different 
time intervals, respectively. The AgNPs showed dose-dependent 
activity on A549 (fig. 9 A-G) and MCF7 (fig. 10 A-G) cell lines in the 
MTT assay; the increase in ROS generation with an increase in 
treatment time of AgNPs significantly inhibits the growth by causing 
damage to the tumour cells of A549 cell line (fig. 11 A-G) and MCF-7 
cell line (fig. 12 A-G) was observed. The anticancer activity was 
evaluated by the conversion of MTT to purple-colored formazan by 
mitochondrial succinate dehydrogenase, and the cytotoxicity was 
determined by the concentration of AgNPs required to minimize the 
survival of tumour cells by 50% (IC50). The biosynthesized AgNPs 
exhibited considerable cytotoxic potential on A549 and MCF-7 cell 
lines with the IC50 values of 69.04 µg/ml and 138.3 µg/ml, respectively, 
and was evidenced by the shrinkage of cancer cells. 
 
 
Fig. 9: MTT assay of Streptomyces sp. PG12 AgNPs on A549 cell line; A) control, B) standard, C) 6.25µg/ml D) 12.5µg/ml, E) 25µg/ml, F) 
50µg/ml, and G) 100µg/ml of AgNPs 
 
 
Fig. 10: MTT assay of Streptomyces sp. PG12 AgNPs on MCF7 cell line; A) control, B) standard, C) 6.25µg/ml D) 12.5µg/ml, E) 25µg/ml, F) 
50µg/ml, and G) 100µg/ml of AgNPs 
 
Similarly, previous studies conducted on the anticancer activities of 
AgNPs against MCF7 [40], CT26 [41], Caco-2 [42], and HePG2 [43] cell 
lines reported that the AgNPs showed dose-dependent activity on 
selected cell lines. The AgNPs treated cells were different from the 
untreated cells in cell shape, size, and other morphological details. In the 
ROS assay study, the treated cells were somewhat granular shaped with 
less well-defined colony morphology. The appearance of dissembled 
gaps between neighboring cells were characteristics of apoptosis, and 
the fluorescent green coloured cells represented necrotic cancer cells, 
which were dead due to the induced ROS. According to the previous 
reports, ROS are free radicals that play a vital role in the living system by 
causing cell damage and cell death. The rapidly increased ROS 
generation was due to the nature of surface, size, shape, and intensity of 
AgNPs. The overproduction of ROS induces apoptosis in several types of 
cancers, and cell death occurs due to an imbalance between pro and anti-
oxidants levels inside the tumour cells [23, 44, 45]. 
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Fig. 11: ROS-mediated anticancer activity of Streptomyces sp. PG12 AgNPs on A549 cell line at different intervals of time; A) 0 min, B) 5 
min, C) 15 min, D) 30 min, E) 60 min, F) 90 min, and G) 120 min of treatment time 
 
 
Fig. 12: ROS-mediated anticancer activity of Streptomyces sp. PG12 AgNPs on MCF7 cell line at different intervals of time; A) 0 min, B) 5 
min, C) 15 min, D) 30 min, E) 60 min, F) 90 min, and G) 120 min of treatment time 
 
CONCLUSION 
The current study describes the synthesis of easy, non-toxic, and 
environmentally friendly extracellular AgNPs from Actinomycete 
isolate Streptomyces sp. PG12 culture supernatant. The primary 
indication regarding AgNPs synthesis was the colour change in 
the reaction mixture and confirmed by the UV-Vis. the 
absorption peak at 421 nm. The biochemical functional groups 
involved in the capping, stabilization, and reduction of AgNPs 
were determined by FTIR analysis, and SEM and TEM 
microscopy ascertained the surface morphology. The spherical 
AgNPs were present in the range of 20 to 32 nm with the 
smallest particle size of 18.91 nm. The biogenic AgNPs showed 
increased antimicrobial activity with lower MIC and MBC values. 
The biosynthesized AgNPs exhibited considerable anticancer 
activity, increasing ROS generation with increased exposure time 
on A549 and MCF-7 cell lines. The present results suggest that, 
Streptomyces sp. PG12 can be used for the mass synthesis of 
biological AgNPs, which could treat multidrug-resistant (MDR) 
microbial infections and as an anticancer agent after successful 
in vivo studies.  
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